Please login to the form below

Not currently logged in
Email:
Password:

Price transparency

This page shows the latest Price transparency news and features for those working in and with pharma, biotech and healthcare.

Pharma reputation lags behind real value, study suggests

Pharma reputation lags behind real value, study suggests

The main factors in pharma’s negative public perception included public drug price debates with the NHS, Brexit stockpiling uncertainties, executive pay, and a lack of transparency over clinical trials. ... At the same time, the Portland survey points

Latest news

  • Countries hail ‘landmark’ drug pricing transparency resolution, despite watering down Countries hail ‘landmark’ drug pricing transparency resolution, despite watering down

    US among those in favour of price transparency. First proposed by Italy, the resolution has now been adopted at the World Health Assembly. ... The US, Japan and Switzerland agreed to support price transparency proposals, but opposed transparency in

  • The magic elixir The magic elixir

    Price transparency and choice: This topic is a book unto itself. ... It tells us what we know: that lack of price/cost transparency is choking our system, and everyone is worse off because of it.

  • The impact of Trump's victory on pharma and healthcare The impact of Trump's victory on pharma and healthcare

    to lower or impose drug price controls will not only reduce its ability to invest in research but will lead to fewer new therapies. ... He has also demanded greater price transparency from all healthcare providers, so that individuals can shop around for

  • Where the patients are... Where the patients are...

    We've spent much time debating and discussing the cost of therapies and how we can ensure price transparency in order to control costs.

  • US lawmaker pushes for drug price transparency US lawmaker pushes for drug price transparency

    If passed a new Bill would demand pharma show how product price tags are worked out.  . ... with a $94, 500 price tag, represent “important breakthroughs in biologic treatments for patients with these conditions”. .

More from news
Approximately 1 fully matching, plus 8 partially matching documents found.

Latest Intelligence

  • Eliminating pharmaceutical rebates, is this déjà vu? Eliminating pharmaceutical rebates, is this déjà vu?

    One of the advantages of using ASP as the benchmark for patient cost-sharing is the improved, though less than complete, price transparency that the metric provides. ... As an alternative, setting coinsurance for high-cost specialty therapies based on

  • US health reforms US health reforms

    level. It’s nothing short of a full-on legislative swarm. Half the states in the union (25) have pending price transparency laws, and at least 30 are crafting various forms ... Earlier this year, a group of physicians at the American Medical

  • India has big plans for healthcare and pharma India has big plans for healthcare and pharma

    Price controls now cover up to 30 per cent of the medicines sold in India. ... But he also urged transparency and greater dialogue over price capping.

  • Interview: Greg Perry, European Generic medicines Association Interview: Greg Perry, European Generic medicines Association

    Companies are facing extreme price cuts and strong competition in the off-patent sector. ... We will be looking at the Price Transparency Directive that is under review by the EC.

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics